Introduction to a standardized method for the evaluation of the potency of Bacillus thuringiensis serotype H-14 based products.

Vector resistance and other constraints have necessitated consideration of the use of alternative materials and methods in an integrated approach to vector control. Bacillus thuringiensis serotype H-14 is a promising biological control agent which acts as a conventional larvicide through its delta-endotoxin (active ingredient) and which now has to be suitably formulated for application in vector breeding habitats. The active ingredient in the formulations has so far not been chemically characterized or quantified and therefore recourse has to be taken to a bioassay method. Drawing on past experience and through the assistance mainly of various collaborating centres, the World Health Organization has standardized a bioassay method (described in the Annex), which gives consistent and reproducible results. The method permits the determination of the potency of a B.t. H-14 preparation through comparison with a standard powder. The universal adoption of the standardized bioassay method will ensure comparability of the results of different investigators.